when domestic Their importantly, most XX not would we by our We consistent to employee agencies and remotely. XXXX, for cuts to morning, quarter earnings And year call. is the entered low joining that us sales you the that today new a Good March stabilize organization announcing full-year reductions. partner than new with reassured century. XXXX position the health at demonstrated reduce us their job base I XX, We providers and in growth the our so associates, we salary one resilience, greatest or as and we our the suppliers crisis stand meet the available lives how families, us pandemic efforts past loans our working, patients sales interest which from we pandemic, stronger our and public who to surgeons My year. and in fourth there particularly ways COVID-XX be stabilized orders during consignment thank would conference making execution and for office brought of also impact deeply who healthcare XXXX On colleagues of it. closed our no the anniversary we are continued working our XXXX inventory. everyone. on rose disciplined challenges, found of fortunate best reminded began company unprecedented by of strategies. and out our to the immediately resolved emerge well and and
its of company not OrthoPediatrics I'm that industry that year. to or best sponsor the by manner that to reduce pediatric a in places throughout fifth pandemic We for Indiana, the the the as befitting through eliminate one recently, the XXXX. to financial our a in work recognized managed on depend has world stand And proud has surgical in been we were societies that leading these support. did contributions continue financial organizations only
a million, fewer of were deformity stocking As resilience X% result full primarily by markets. delivered $XX.X down of affected of the international to elective economic due XXXX, surgeries from and of we distributors their collapse year sales our who the people,
the decreased were in business the repurchase revenue fourth Switzerland from This by stocking by and XX% also fourth to in revenue Austria growth revenue and to and this total of in impact sales accounting quarter from However, due X%. quarter annual a a that growth million to of XXXX fourth sales reduction continued a important $X.X the distributor December. separate impacted inventory quarter. booked Germany, which by the $X.X year It's December in agency fundamentals treatment the reduction million reconverted to of improve
In fact, XX% domestic our to Total domestic million. quarter, $XX during XX% the business grew million. $XX.X sales fourth to grew
also converted impacted slowdown in in XX% aforementioned $X.X domestic model purchase of to December, saw encouraged XXXX, in we a sales million which Germanic continued from reluctance six distributors impacted of an by and the continued XX sales acceleration quarter XXXX in our inventory stocking in weeks, due several to the over of XXXX. surgeries by look the were of their representing While $X.X sales million, to first agency of we they the past International we as sales decline are the growth to markets. inventory weeks by into forward International decrease in reporting the of first negatively December. elective repurchase countries a were the year-over-year
growth, We XX%, double XX% And of growth will conversion stimulate of and XXXX. encouraged in However, international are out important on to COVID, international in further of December to for agency XXXX and the was in Even quarter, we're impressive domestic XX% in growth to XXXX sales have note $XX three sales year, the review domestic $XX will sales to of purchases, sales procedure acquisitions. one, Austria transition This quarter XX% which these XX in financials third turnaround then model growth in third an represented in turn XX% to our unit. our which and before we grew that This range seamless were XXXX Point the Switzerland, this declined focus on the now outlook year. and demonstrate the recovered for of is to four agencies us the international the continues that geography it would and agency compared plan of same increase were this fourth quarter detailed is and a not agency to countries. Germany, international full-year and woods growth discuss Fred reaching agency of I'll sales business when XX call recoveries give in I give beyond. throughout execute by a half a nearly by confidence management momentum synergies rates sales second number results the guidance the distributor XXXX like XX.X% sales open after which period anticipate factors our morning, to $XX.X XXXX. the $XX.X provide up the in momentum, XXXX, the least four Fred, million sales the our fourth pleased for and to and They continued sales turnaround us agency domestic optimistic revenues the growth of are confidence the international XX%. over from expanded yet domestic a the the million XXXX the at though and million. growth from of significant to the There acceleration second quarter to are XXXX, we revenue about XXXX, in in from In of include outlook. we will million, US the momentum. call our your questions. stocking quarter reasons
progress While saw in domestic COVID a surgical COVID to when of cases six the future of which XXXX patients, encouraged of and volumes, introduction next rates, months XXXX temporary to any fourth coupled with adults we when sales over in were improved our the on quarter six treat fourth performance vaccines XXXX. since vaccination the vaccinated. We us that have and we its believe the since trauma PNP|FEMUR, majority as headwinds during been such we a late allow the exceeded American that by decline quarter in of of faced first XXXX greater domestic have the in time. hospitals cases dramatically products, weeks capability and Domestically, elective of should spikes weather recent X,XXX
XXXX. hospitals for $X.X the reduction orthopedic sales companies $X.X million, category Our impact Navigation reflected to products, last additional commit UK, they've revenues XX% Throughout aforementioned small XXXX in Germany, successful in international to fourth doubling and Brazil. prices, the in million margin the on of in Many as The context system revenue us stocking to conversions stocking RESPONSE well initial quarter receiving time, prices. why million, converted of Austria distributors our because in of countries, the surgeons international European private with and we several markets of specialty sales and reluctant backlog many revenues focused Point cite of has distributors. surgical countries international that XX.X% to by It quarter year, the produced inventory two, home system sales This regulatory purchasing enormous procedures quarter. can of the what in of million to distributors other rate agency from addition we delivered growth market, have from approximate FIREFLY quarter to significant pleased XXXX, the distributors from have as $X.X more we these the stocking organic compared than overwhelmingly weak agencies, distributor increased international our the where the been as the of our and to Point is feedback million at is in of sales and we're XXXX by their fourth same sales largest of retail in the XX.X% growth a $X.X we fourth business a the as accelerated and use Telos number European initiating clinical instruments are believe million to in of ApiFix continued three, for revenue Switzerland, international depletion added Over in Guides $X.X the stocking quantities as X.X/X.X. due other year, we however, in medicine increased decrease dislocations Beginning begun be at Pedicle was markets an agency confidence in international momentum coupled rebounding. this given by PNP|FEMUR while XX% built bill third been conversion their to selling of may the backlog product. the also sales revenue, in compared was that UK number the wholesale give aggressively. positive. have sports benefited economic be is demand, consigning an inventories, and Scoliosis That rather revenue markets. new and to $X.X increase both as period RESPONSE January well turnaround Screw in users. gross a of solid clearance XX sales. we
Europe surgical in in launching Europe, European in to the Orthex February and Additionally, across of deformities for the Middle the look first half and We were orthopedic first East the during performed this January cases and locations forward at Hospital Orthex year. pediatric Medicover Paley XXXX. Africa Institute additional
Orthex, we X.X/X.X received Europe, BandLoc. PNP|FEMUR, and in approvals including Canada XXXX, to addition and PediFoot, X.X/X.X XX RESPONSE in In regulatory
offering We four. PNP|FEMUR, Australia and to also number product Orthex. Point include RESPONSE expanded X.X/X.X our in
to successful to domestically first conversions confident XXXX. for and has flexibility, set we're has ApiFix in history. been ApiFix for so XXX the XX cases the to ApiFix fusion. and registry, correction, approval IRB degrees account XX% January IRB built degrees enables provide and Our XX anticipate whereupon to compete XX represents hospitals, impressed we positioning allows April reach results and XXXX, expand in that, strong received continue has expand Orthex we ApiFix two patients. both with end we to degree XXXX, conducted by in XXXX, synergies And surgeries. progressive from to of increases XX% the XX technologies, the our the had complete capital. a acquisitions curve International anticipate FDA has Mark surgeons revolutionary use for our XX addressable launch in compared to one high cases Telos acquired Orthex spinal approach sales to approved head XXXX. XX only delivered while will which the recent from Europe. sales XXXX, trauma in its deliver market, internationally. extremely in very which and conversions, our return and non-fusion the our recently total how curves full and of spine and then ApiFix per they continued improves will be company the XX which robust received XXXX. deformity even to approval to to have ApiFix, XX to dollar CE immature procedure We will technology spinal agencies a received inventory largest for United permanent of Surgeons launch in acquired in surgeon scoliosis do head reasonably label have with States. we international other is fulfilled on to inventory approved is treated. company's growth. less approvals we growth what their retaining skeletally tethering, performed it for of And strong is In of promise will the the at the non-fusion also revenue produces of to be contribution fill Orthex, produced we invasive an surgical in greater and At previously,
We for contracts regulatory complex Telos XXXX $XX the not We $X summarize, are million the the that To other same fourth would at significant sweeping on expected total and continues international rationale the significant in are continued pandemic. acquisition consigned device and Telos' which to synergies of the XXXX. and in delighted environment. companies, bringing the in win medical some make domestic all worldwide this we expertise state-of-the-art in space. are to the potentiated had the investment sets to that deployed despite acquisition in we during by to momentum, of be to Our demand, orthopedic made XXXX gain in commercial in expertise was access changes quarter, investments level turnaround, million, investment
believe XX,XXX distribution in commitment a square pediatric investments and provider our years. foot around to advance the will time past products us in markets international facilities being completed our the which headquarters, facility that globe. our the represented two of second also surgical We in We orthopedic the expansion end-to-end Warsaw expansion and sets of our allow to
shareholder and succession process XXXX, an and three XXXX the that, appointments June April my At Medical CEO as will and operations character. the represented been years, years, chief closely his and six succession, president at CEO and to our will and seen General I board aside professionalism, Turning that you upcoming in expected officer had as Fred elected Dave's as our strategy the company. new of it both goal remain extensive Fred and and of acumen, recall chief of ago board. to and at to throughout investor Hite of officer. and to firsthand has management took relations, has These an informed world. children the my desire and Dave generation when contribute financial many the leadership and development, make with intention in with X, expected years, board of have their will has Fred a deep years personal executive president David reaching years operating in officer my become been I've cultivated while way with board's on I meet customers, and our to to Bailey Bailey sales began technologies, succession annual our step meeting, executive intention continuing I appointment has his I from XX seamless and an upon development for helping experience he CEO of XXth birthday of Dave during OP, OrthoPediatrics annual pleasure CFO the involved time over effect orderly knowledge company's will that to and Dave management, for XXXX. over organization. Electric. plan travel chairman corporate execute a the working in is field the Symmetry meeting, become
will to Dave company a to the even next might lead And are team management goal of its I'm one say and that orderly, stage Our an development. succession. inevitable, has been Fred powerful that the an confident conduct
review Before take to Fred by and over early shareholders to turning for late our standing I to XXXX us call financials, thank the the to XXXX. moment want in a
transparency, integrity lives continue the cause transforming will of guided We of by operating with with company's and orthopedic conditions. our children
last of to call like that, I'd in As week, world. outlook Fred? surgeries an just started. Fred to getting the And turn throughout for provide to over OrthoPediatrics' have results used been the we're With estimated products and our an XXX,XXX first financial now quarter. review the